INVO Fertility (IVF) Operating Margin Growth (1y) (2012 - 2026)

INVO Fertility (IVF) Operating Margin Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -430.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 128.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 301.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 102.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 851.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 241.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -313.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 INVO Fertility 1,108.74 -4.90 Mn 732,978.00 -568.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -568.00
Sep 30, 2025 -234.00
Jun 30, 2025 -5,955.00
Mar 31, 2025 2,240.00
Dec 31, 2024 -9,630.00
Sep 30, 2024 17.00
Jun 30, 2024 55,310.00
Mar 31, 2024 56,705.00
Dec 31, 2023 86,814.00
Sep 30, 2023 98,227.00
Jun 30, 2023 118,117.00
Mar 31, 2023 99,840.00
Dec 31, 2022 -99,383.00
Sep 30, 2022 -3,435.00
Jun 30, 2022 -93,022.00
Mar 31, 2022 -143,325.00
Dec 31, 2021 92,598.00
Sep 30, 2021 -66,160.00
Jun 30, 2021 -47,299.00
Mar 31, 2021 31,223.00